OR5D17P

Across TCGA pan-cancer cohorts, OR5D17P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated OR5D17P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher OR5D17P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5D17P expression acts as an unfavorable survival marker.

BRCA, DLBC, and KIRP are the cancer types where OR5D17P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
DLBC	DFS	Tertile	All	0.399	0.796	.032	18	view →
KIRP	OS	Tertile	All	0.326	0.728	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OR5D17P–BRCA (DFS)

Open the BRCA breakdown →